Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancer. [electronic resource] by
- Perren, T J
- Clayton, R N
- Blackledge, G
- Bailey, L C
- Holder, G
- Lynch, S S
- Arkell, D G
- Cottam, J
- Farrar, D
- Young, C H
Producer: 19861119
In:
Cancer chemotherapy and pharmacology vol. 18
Availability: No items available.
|
|
31.
|
|
|
32.
|
Phase II study of Zoladex depot in advanced prostatic cancer with special reference to criteria of response and survival. [electronic resource] by
- Emtage, L A
- Perren, T J
- Stuart, N S
- Arkell, D G
- Wallace, D M
- Hughes, M A
- Cottam, J
- Farrar, D
- Young, C H
- Blackledge, G R
Producer: 19880302
In:
British journal of urology vol. 60
Availability: No items available.
|